Suppr超能文献

肝切除术和为结直肠癌转移灶就诊于多家癌症中心与肝转移的关系。

Association of Liver Resection and Visiting More Than One Commission on Cancer Hospital for Colorectal Cancer With Liver Metastasis.

机构信息

Division of Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.

Division of Surgical Oncology, Brigham and Women's Hospital, Boston, Massachusetts.

出版信息

J Surg Res. 2022 Nov;279:247-255. doi: 10.1016/j.jss.2022.06.003. Epub 2022 Jul 4.

Abstract

INTRODUCTION

Despite the advances in treatment, there are low rates of liver metastasectomy for colorectal cancer with liver metastasis (CRLM) in the United States. The aim of this study was to investigate the association between likelihood of liver metastasectomy for CRLM and seeking care at >1 versus 1 Commission on Cancer (CoC) hospital.

METHODS

We performed a retrospective analysis of the National Cancer Database (2011-2017) for patients with CRLM. Patients were grouped based on seeking care at 1 CoC hospital or >1 CoC hospital. An adjusted multivariable Poisson regression interaction analysis was used to evaluate likelihood of liver metastasectomy for CRLM according to race and whether care was sought at >1 CoC hospital.

RESULTS

We identified 25,956 patients with CRLM without extra-hepatic disease. 23,088 (89.0%) patients visited 1 CoC hospital and 2868 (11.1%) visited >1 CoC hospital. Black patients were less likely to seek care at >1 CoC hospital (relative risk [RR] 0.68, confidence intervalCI 0.60-0.76, P < 0.001). Undergoing liver metastasectomy was associated with higher likelihood of seeking care at >1 CoC hospital (RR 1.27, CI 1.26-1.52, P < 0.001). Among patients who sought care at >1 CoC hospital, there was no significant difference between White and Black patients undergoing liver metastasectomy (RR 0.86, 95% CI 0.71-1.04, P = 0.11).

CONCLUSIONS

Patients with CRLM who sought care at >1 CoC hospital were more likely to undergo a liver metastasectomy. Among White and Black patients who sought care at >1 CoC hospital, there was no difference in likelihood of undergoing a liver metastasectomy.

摘要

简介

尽管治疗取得了进展,但美国结直肠癌伴肝转移(CRLM)患者接受肝转移切除术的比例仍然较低。本研究旨在探讨 CRLM 患者是否选择在多家癌症委员会(CoC)认证医院接受治疗与接受肝转移切除术的可能性之间的关系。

方法

我们对 2011 年至 2017 年国家癌症数据库(National Cancer Database)中的 CRLM 患者进行了回顾性分析。患者根据是否在一家 CoC 医院或多家 CoC 医院就诊进行分组。采用调整后的多变量泊松回归交互分析,根据种族和是否在多家 CoC 医院就诊,评估 CRLM 患者行肝转移切除术的可能性。

结果

我们共纳入 25956 例无肝外疾病的 CRLM 患者。23088 例(89.0%)患者在一家 CoC 医院就诊,2868 例(11.1%)患者在多家 CoC 医院就诊。黑人患者在多家 CoC 医院就诊的可能性较低(相对风险[RR]0.68,95%置信区间[CI]0.60-0.76,P<0.001)。行肝转移切除术与在多家 CoC 医院就诊的可能性较高相关(RR 1.27,95%CI 1.26-1.52,P<0.001)。在多家 CoC 医院就诊的患者中,白人患者和黑人患者行肝转移切除术的可能性没有显著差异(RR 0.86,95%CI 0.71-1.04,P=0.11)。

结论

在 CRLM 患者中,在多家 CoC 医院就诊的患者更有可能接受肝转移切除术。在在多家 CoC 医院就诊的白人患者和黑人患者中,行肝转移切除术的可能性没有差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验